![](/img/cover-not-exists.png)
A randomized phase III trial of docetaxel (D) and cisplatin (P) versus vindesine (V) and p in stage IV non small cell lung cancer (NSCLC)
Y. Nishiwaki, H. Kunitoh, K. Noda, Y. Ichinose, N. Katakami, T. Sugiura, M. Kawahara, A. Yokoyama, H. Niitani, K. WatanabeVolume:
37
Year:
2001
Language:
english
DOI:
10.1016/s0959-8049(01)80657-2
File:
PDF, 163 KB
english, 2001